title: Synthetic cannabis-induced mania.
abstract: Synthetic cannabinoids (SC), cannabinoid 1 and cannabinoid 2 receptors agonists, are the psychoactive substances. SC was originally produced to treat medical conditions. Compared to other narcotics, SC is easier to obtain, cheap, and highly potent and has a long half-life. In addition, routine analysis does not detect SC, which has led to widespread use. A case is presented that manic episode was developed with the use of SC. Hospitalization and admission to psychiatric units depending on SC use have been observed mostly with psychosis. Although SC-induced affective symptoms were mentioned in the literature, mania has not been reported before. We aimed to discuss the psychiatric conditions induced by widespread use of SC via our case.
authors.affiliation: Department of Psychiatry, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey.
authors.forename: Mehmet Fatih
authors.initials: MF
authors.lastname: Ustundag
authors.affiliation: Department of Child and Adolescent Psychiatry, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey.
authors.forename: Esra
authors.initials: E
authors.lastname: Ozhan Ibis
authors.affiliation: Department of Psychiatry, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey.
authors.forename: Atakan
authors.initials: A
authors.lastname: Yucel
authors.affiliation: Department of Psychiatry, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey.
authors.forename: Halil
authors.initials: H
authors.lastname: Ozcan
references.citation: Arch Gen Psychiatry. 2010 May;67(5):440-7
references.pmid: 20194820
references.citation: Psychol Med. 2009 Oct;39(10):1607-16
references.pmid: 19335936
references.citation: Ann Emerg Med. 2011 Feb;57(2):187-8
references.pmid: 21251535
references.citation: J Anal Toxicol. 2010 Jun;34(5):252-60
references.pmid: 20529459
references.citation: Am J Psychiatry. 2011 Oct;168(10):1119
references.pmid: 21969050
references.citation: J Affect Disord. 2015 Jan 15;171:39-47
references.pmid: 25285897
references.citation: Ann Emerg Med. 2012 Oct;60(4):435-8
references.pmid: 22575211
references.citation: J Mass Spectrom. 2009 May;44(5):832-7
references.pmid: 19189348
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):219-20
references.pmid: 23026141
references.citation: Toxicol Lett. 2010 Sep 1;197(3):157-62
references.pmid: 20566335